of the reasons selected for stopping treatment were organisational or clinic problems.
22 studies, 21,453 patients, 8 countries, 2012. 11.68% plus 7.71%; the sum is ours. A share of selections, not of patients.
Peer-reviewedGameiro et al., Human Reproduction Update ↗


